1. Home
  2. SLDPW vs CRL Comparison

SLDPW vs CRL Comparison

Compare SLDPW & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLDPW
  • CRL
  • Stock Information
  • Founded
  • SLDPW 2011
  • CRL 1947
  • Country
  • SLDPW United States
  • CRL United States
  • Employees
  • SLDPW 260
  • CRL N/A
  • Industry
  • SLDPW Electrical Products
  • CRL Biotechnology: Commercial Physical & Biological Resarch
  • Sector
  • SLDPW Energy
  • CRL Health Care
  • Exchange
  • SLDPW Nasdaq
  • CRL Nasdaq
  • Market Cap
  • SLDPW N/A
  • CRL 7.3B
  • IPO Year
  • SLDPW N/A
  • CRL 2000
  • Fundamental
  • Price
  • SLDPW $0.47
  • CRL $152.26
  • Analyst Decision
  • SLDPW
  • CRL Buy
  • Analyst Count
  • SLDPW 0
  • CRL 15
  • Target Price
  • SLDPW N/A
  • CRL $186.64
  • AVG Volume (30 Days)
  • SLDPW 47.0K
  • CRL 732.3K
  • Earning Date
  • SLDPW 02-27-2025
  • CRL 11-05-2025
  • Dividend Yield
  • SLDPW N/A
  • CRL N/A
  • EPS Growth
  • SLDPW N/A
  • CRL N/A
  • EPS
  • SLDPW N/A
  • CRL N/A
  • Revenue
  • SLDPW $18,026,000.00
  • CRL $4,028,615,000.00
  • Revenue This Year
  • SLDPW N/A
  • CRL N/A
  • Revenue Next Year
  • SLDPW N/A
  • CRL $1.94
  • P/E Ratio
  • SLDPW N/A
  • CRL N/A
  • Revenue Growth
  • SLDPW N/A
  • CRL N/A
  • 52 Week Low
  • SLDPW $0.17
  • CRL $91.86
  • 52 Week High
  • SLDPW $0.33
  • CRL $230.02
  • Technical
  • Relative Strength Index (RSI)
  • SLDPW N/A
  • CRL 40.80
  • Support Level
  • SLDPW N/A
  • CRL $152.18
  • Resistance Level
  • SLDPW N/A
  • CRL $159.78
  • Average True Range (ATR)
  • SLDPW 0.00
  • CRL 5.79
  • MACD
  • SLDPW 0.00
  • CRL -1.08
  • Stochastic Oscillator
  • SLDPW 0.00
  • CRL 17.49

About SLDPW Solid Power Inc. Warrant

Solid Power Inc is engaged in solid-state battery technology and manufacturing processes. Its core technology is a sulfide-based solid electrolyte material, which replaces the liquid or gel electrolyte used in traditional lithium-ion battery cells. Its commercialization plan is to manufacture and sell electrolytes to Tier 1 battery manufacturers and automotive original equipment manufacturers (OEMs) that choose to produce its battery cells.

About CRL Charles River Laboratories International Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Share on Social Networks: